# Phase 2 Study of Obeticholic Acid for Lipodystrophy Patients

> **NCT02430077** · PHASE2 · COMPLETED · sponsor: **Abhimanyu Garg** · enrollment: 10 (actual)

## Conditions studied

- Familial Partial Lipodystrophy

## Interventions

- **DRUG:** Obeticholic Acid
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02430077
- **Lead sponsor:** Abhimanyu Garg
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2022-10
- **Final completion:** 2022-12
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2024-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02430077

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02430077, "Phase 2 Study of Obeticholic Acid for Lipodystrophy Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02430077. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*